A
ADRX
ADARx Pharmaceuticals
13.29
-1.67-11.16%After Hours: 13.29 0.00 0.00%19:30 11/05 EST
OPEN/PREV CLOSE14.97/14.96
TODAY RANGE12.75-15.39
VOL781.16K
MARKET CAP1.42B
52 WEEK RANGE12.75-23.21
AVG VOL (3M)673.78K
% TURNOVER0.68%
TURNOVER--
P/E (TTM)-29.3119
% RANGE17.65%
EPS(TTM)-0.4534
P/E(FORWARD)-6.7582
P/B13.32
BVPS0.9978
DIVIDEND--
P/S411.46
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP859.79M
SHARES OUTSTANDING106.80M
NEXT EARNINGS--
FREE FLOAT64.69M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·10/29 19:12
Russell 2000 estimated to add 107 stocks in December rebalance - Stephens
Benzinga·10/20 14:06
TD Cowen Initiates Coverage On Adarx Pharmaceuticals with Buy Rating
Dow Jones·10/20 12:58
ADARx Pharmaceuticals Initiated at Overweight by JP Morgan
Dow Jones·10/20 12:58
ADARx Pharmaceuticals Price Target Announced at $38.00/Share by JP Morgan
Dow Jones·10/20 12:36
ADARx Pharmaceuticals Price Target Announced at $35.00/Share by UBS
Benzinga·10/20 12:31
This Restaurant Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
TipRanks·10/20 11:00
ADARx Pharmaceuticals initiated with an Outperform at LifeSci Capital
Dow Jones·10/20 10:04
ADARx Pharmaceuticals Price Target Announced at $32.00/Share by Morgan Stanley
TipRanks·10/20 09:05
ADARx Pharmaceuticals initiated with a Buy at TD Cowen
TipRanks·10/20 09:00
ADARx Pharmaceuticals initiated with an Overweight at Morgan Stanley
TipRanks·10/20 09:00
ADARx Pharmaceuticals initiated with a Buy at UBS
TipRanks·10/19 16:00
Opening Day: Biotech duo City Therapeutics, Iambic make debuts
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others